Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Prevention)”

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04639375
What this trial is testing

Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19)

Who this might be right for
SARS-CoV-2
E-MO Biology Inc 300
Testing effectiveness (Phase 2)Study completedNCT04568031
What this trial is testing

Study of AZD1222 for the Prevention of COVID-19 in Japan

Who this might be right for
COVID-19
AstraZeneca 256
Large-scale testing (Phase 3)Study completedNCT04672395
What this trial is testing

A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19

Who this might be right for
COVID-19
Clover Biopharmaceuticals AUS Pty 31,454
Not applicableActive Not RecruitingNCT05346042
What this trial is testing

Safe and Timely Cessation of Isolation of Patients With COVID-19 (The SCIP-COVID-19) Study

Who this might be right for
COVID-19
Anne Voor in 't holt 7,000
Not applicableUnknownNCT04723459
What this trial is testing

Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff

Who this might be right for
Covid-19
South Valley University 150
Early research (Phase 1)Ended earlyNCT04526912
What this trial is testing

Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection

Who this might be right for
Acute Lung Injury
Viela Bio 10
Post-approval studies (Phase 4)Study completedNCT04409834
What this trial is testing

Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial

Who this might be right for
COVID-19Venous ThromboembolismArterial Thrombosis
The TIMI Study Group 390
Large-scale testing (Phase 3)Study completedNCT04328467
What this trial is testing

Pre-exposure Prophylaxis for SARS-Coronavirus-2

Who this might be right for
COVID-19Corona Virus InfectionARDS+1 more
University of Minnesota 1,483
Not applicableStudy completedNCT04668625
What this trial is testing

Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures

Who this might be right for
COVID-19 (SARS-CoV-2)
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 1,000
Large-scale testing (Phase 3)Study completedNCT04534725
What this trial is testing

COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;

Who this might be right for
CancerCovid19Respiratory Viral Infection
Peter MacCallum Cancer Centre, Australia 441
Testing effectiveness (Phase 2)Ended earlyNCT04409327
What this trial is testing

Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes

Who this might be right for
COVID19
Restorbio Inc. 36
Not applicableStudy completedNCT04379037
What this trial is testing

Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
Nemechek Technologies 50
Large-scale testing (Phase 3)Study completedNCT04908722
What this trial is testing

Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults

Who this might be right for
COVID-19 Prevention
Janssen Vaccines & Prevention B.V. 1,609
Testing effectiveness (Phase 2)Study completedNCT04348695
What this trial is testing

Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.

Who this might be right for
Coronavirus Infection
Fundación de investigación HM 94
Not applicableUnknownNCT04777981
What this trial is testing

(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC

Who this might be right for
COVID-19SAR
Anewsha Therapeutics Inc. 60
Early research (Phase 1)Study completedNCT04619628
What this trial is testing

Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19

Who this might be right for
COVID-19
Codagenix, Inc 48
Not applicableStudy completedNCT04303507
What this trial is testing

Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting

Who this might be right for
COVID19CoronavirusAcute Respiratory Illnesses
University of Oxford 4,652
Large-scale testing (Phase 3)Ended earlyNCT04904549
What this trial is testing

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older

Who this might be right for
COVID-19
Sanofi Pasteur, a Sanofi Company 23,670
Post-approval studies (Phase 4)Study completedNCT04911790
What this trial is testing

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 131,650
Testing effectiveness (Phase 2)UnknownNCT04902183
What this trial is testing

Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19

Who this might be right for
Covid19
Athens Medical Society 90
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation